nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—CYP2E1—Dacarbazine—pancreatic cancer	0.0506	0.37	CbGbCtD
Dalfampridine—KCNH2—Sunitinib—pancreatic cancer	0.0457	0.334	CbGbCtD
Dalfampridine—CYP2E1—Tamoxifen—pancreatic cancer	0.0402	0.295	CbGbCtD
Dalfampridine—Infestation NOS—Sunitinib—pancreatic cancer	0.00465	0.00801	CcSEcCtD
Dalfampridine—Infestation—Sunitinib—pancreatic cancer	0.00465	0.00801	CcSEcCtD
Dalfampridine—Urinary tract infection—Sunitinib—pancreatic cancer	0.00452	0.00778	CcSEcCtD
Dalfampridine—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00434	0.00748	CcSEcCtD
Dalfampridine—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.00426	0.00733	CcSEcCtD
Dalfampridine—Mental disorder—Erlotinib—pancreatic cancer	0.00422	0.00728	CcSEcCtD
Dalfampridine—Back pain—Tamoxifen—pancreatic cancer	0.0041	0.00707	CcSEcCtD
Dalfampridine—Connective tissue disorder—Sunitinib—pancreatic cancer	0.0041	0.00706	CcSEcCtD
Dalfampridine—Back pain—Erlotinib—pancreatic cancer	0.00406	0.00699	CcSEcCtD
Dalfampridine—Angioedema—Tamoxifen—pancreatic cancer	0.00388	0.00668	CcSEcCtD
Dalfampridine—Angiopathy—Sunitinib—pancreatic cancer	0.00379	0.00652	CcSEcCtD
Dalfampridine—Immune system disorder—Sunitinib—pancreatic cancer	0.00377	0.00649	CcSEcCtD
Dalfampridine—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00376	0.00648	CcSEcCtD
Dalfampridine—Infestation NOS—Fluorouracil—pancreatic cancer	0.00367	0.00632	CcSEcCtD
Dalfampridine—Infestation—Fluorouracil—pancreatic cancer	0.00367	0.00632	CcSEcCtD
Dalfampridine—Mental disorder—Sunitinib—pancreatic cancer	0.00366	0.0063	CcSEcCtD
Dalfampridine—Chest pain—Tamoxifen—pancreatic cancer	0.00361	0.00622	CcSEcCtD
Dalfampridine—Anxiety—Tamoxifen—pancreatic cancer	0.0036	0.0062	CcSEcCtD
Dalfampridine—Chest pain—Erlotinib—pancreatic cancer	0.00357	0.00615	CcSEcCtD
Dalfampridine—Urinary tract infection—Fluorouracil—pancreatic cancer	0.00356	0.00614	CcSEcCtD
Dalfampridine—Anxiety—Erlotinib—pancreatic cancer	0.00356	0.00613	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00355	0.00611	CcSEcCtD
Dalfampridine—Back pain—Sunitinib—pancreatic cancer	0.00351	0.00605	CcSEcCtD
Dalfampridine—Infection—Tamoxifen—pancreatic cancer	0.00344	0.00592	CcSEcCtD
Dalfampridine—Infection—Erlotinib—pancreatic cancer	0.0034	0.00586	CcSEcCtD
Dalfampridine—Connective tissue disorder—Irinotecan—pancreatic cancer	0.00338	0.00582	CcSEcCtD
Dalfampridine—Nervous system disorder—Erlotinib—pancreatic cancer	0.00336	0.00579	CcSEcCtD
Dalfampridine—Skin disorder—Erlotinib—pancreatic cancer	0.00333	0.00573	CcSEcCtD
Dalfampridine—Angioedema—Sunitinib—pancreatic cancer	0.00332	0.00572	CcSEcCtD
Dalfampridine—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.00329	0.00567	CcSEcCtD
Dalfampridine—Convulsion—Sunitinib—pancreatic cancer	0.00315	0.00542	CcSEcCtD
Dalfampridine—Insomnia—Tamoxifen—pancreatic cancer	0.00313	0.00539	CcSEcCtD
Dalfampridine—Angiopathy—Irinotecan—pancreatic cancer	0.00312	0.00537	CcSEcCtD
Dalfampridine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00311	0.00535	CcSEcCtD
Dalfampridine—Immune system disorder—Irinotecan—pancreatic cancer	0.0031	0.00535	CcSEcCtD
Dalfampridine—Mediastinal disorder—Irinotecan—pancreatic cancer	0.0031	0.00534	CcSEcCtD
Dalfampridine—Insomnia—Erlotinib—pancreatic cancer	0.0031	0.00534	CcSEcCtD
Dalfampridine—Chest pain—Sunitinib—pancreatic cancer	0.00309	0.00533	CcSEcCtD
Dalfampridine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00309	0.00532	CcSEcCtD
Dalfampridine—Nasopharyngitis—Docetaxel—pancreatic cancer	0.00307	0.00529	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00307	0.00529	CcSEcCtD
Dalfampridine—Dyspnoea—Erlotinib—pancreatic cancer	0.00305	0.00526	CcSEcCtD
Dalfampridine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00305	0.00525	CcSEcCtD
Dalfampridine—Angiopathy—Gemcitabine—pancreatic cancer	0.00304	0.00523	CcSEcCtD
Dalfampridine—Immune system disorder—Gemcitabine—pancreatic cancer	0.00302	0.00521	CcSEcCtD
Dalfampridine—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00302	0.0052	CcSEcCtD
Dalfampridine—Dyspepsia—Erlotinib—pancreatic cancer	0.00301	0.00519	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00299	0.00515	CcSEcCtD
Dalfampridine—Constipation—Tamoxifen—pancreatic cancer	0.00296	0.0051	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00296	0.00509	CcSEcCtD
Dalfampridine—Infection—Sunitinib—pancreatic cancer	0.00295	0.00507	CcSEcCtD
Dalfampridine—Constipation—Erlotinib—pancreatic cancer	0.00293	0.00505	CcSEcCtD
Dalfampridine—Nervous system disorder—Sunitinib—pancreatic cancer	0.00291	0.00501	CcSEcCtD
Dalfampridine—Back pain—Irinotecan—pancreatic cancer	0.00289	0.00499	CcSEcCtD
Dalfampridine—Skin disorder—Sunitinib—pancreatic cancer	0.00288	0.00496	CcSEcCtD
Dalfampridine—Back pain—Gemcitabine—pancreatic cancer	0.00282	0.00486	CcSEcCtD
Dalfampridine—Urticaria—Tamoxifen—pancreatic cancer	0.00275	0.00474	CcSEcCtD
Dalfampridine—Insomnia—Sunitinib—pancreatic cancer	0.00268	0.00462	CcSEcCtD
Dalfampridine—Paraesthesia—Sunitinib—pancreatic cancer	0.00266	0.00459	CcSEcCtD
Dalfampridine—Infestation NOS—Docetaxel—pancreatic cancer	0.00265	0.00456	CcSEcCtD
Dalfampridine—Infestation—Docetaxel—pancreatic cancer	0.00265	0.00456	CcSEcCtD
Dalfampridine—Dyspnoea—Sunitinib—pancreatic cancer	0.00264	0.00455	CcSEcCtD
Dalfampridine—Dyspepsia—Sunitinib—pancreatic cancer	0.00261	0.0045	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00256	0.00441	CcSEcCtD
Dalfampridine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00255	0.00439	CcSEcCtD
Dalfampridine—Constipation—Sunitinib—pancreatic cancer	0.00254	0.00437	CcSEcCtD
Dalfampridine—Asthenia—Tamoxifen—pancreatic cancer	0.00248	0.00428	CcSEcCtD
Dalfampridine—Convulsion—Fluorouracil—pancreatic cancer	0.00248	0.00428	CcSEcCtD
Dalfampridine—Chest pain—Gemcitabine—pancreatic cancer	0.00248	0.00428	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00246	0.00425	CcSEcCtD
Dalfampridine—Confusional state—Irinotecan—pancreatic cancer	0.00246	0.00424	CcSEcCtD
Dalfampridine—Asthenia—Erlotinib—pancreatic cancer	0.00246	0.00423	CcSEcCtD
Dalfampridine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00244	0.00421	CcSEcCtD
Dalfampridine—Chest pain—Fluorouracil—pancreatic cancer	0.00244	0.0042	CcSEcCtD
Dalfampridine—Infection—Irinotecan—pancreatic cancer	0.00243	0.00418	CcSEcCtD
Dalfampridine—Nervous system disorder—Irinotecan—pancreatic cancer	0.00239	0.00413	CcSEcCtD
Dalfampridine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00238	0.0041	CcSEcCtD
Dalfampridine—Infection—Gemcitabine—pancreatic cancer	0.00236	0.00407	CcSEcCtD
Dalfampridine—Confusional state—Fluorouracil—pancreatic cancer	0.00236	0.00406	CcSEcCtD
Dalfampridine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00234	0.00403	CcSEcCtD
Dalfampridine—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00234	0.00402	CcSEcCtD
Dalfampridine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00233	0.00402	CcSEcCtD
Dalfampridine—Infection—Fluorouracil—pancreatic cancer	0.00232	0.004	CcSEcCtD
Dalfampridine—Skin disorder—Gemcitabine—pancreatic cancer	0.00231	0.00398	CcSEcCtD
Dalfampridine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00229	0.00395	CcSEcCtD
Dalfampridine—Dizziness—Tamoxifen—pancreatic cancer	0.00229	0.00394	CcSEcCtD
Dalfampridine—Hypotension—Irinotecan—pancreatic cancer	0.00228	0.00393	CcSEcCtD
Dalfampridine—Dizziness—Erlotinib—pancreatic cancer	0.00226	0.0039	CcSEcCtD
Dalfampridine—Hypotension—Gemcitabine—pancreatic cancer	0.00222	0.00383	CcSEcCtD
Dalfampridine—Insomnia—Irinotecan—pancreatic cancer	0.00221	0.00381	CcSEcCtD
Dalfampridine—Vomiting—Tamoxifen—pancreatic cancer	0.0022	0.00379	CcSEcCtD
Dalfampridine—Paraesthesia—Irinotecan—pancreatic cancer	0.00219	0.00378	CcSEcCtD
Dalfampridine—Hypotension—Fluorouracil—pancreatic cancer	0.00219	0.00377	CcSEcCtD
Dalfampridine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00218	0.00376	CcSEcCtD
Dalfampridine—Rash—Tamoxifen—pancreatic cancer	0.00218	0.00376	CcSEcCtD
Dalfampridine—Dermatitis—Tamoxifen—pancreatic cancer	0.00218	0.00376	CcSEcCtD
Dalfampridine—Vomiting—Erlotinib—pancreatic cancer	0.00218	0.00375	CcSEcCtD
Dalfampridine—Dyspnoea—Irinotecan—pancreatic cancer	0.00218	0.00375	CcSEcCtD
Dalfampridine—Headache—Tamoxifen—pancreatic cancer	0.00217	0.00374	CcSEcCtD
Dalfampridine—Rash—Erlotinib—pancreatic cancer	0.00216	0.00372	CcSEcCtD
Dalfampridine—Dermatitis—Erlotinib—pancreatic cancer	0.00216	0.00372	CcSEcCtD
Dalfampridine—Angiopathy—Docetaxel—pancreatic cancer	0.00216	0.00371	CcSEcCtD
Dalfampridine—Insomnia—Gemcitabine—pancreatic cancer	0.00215	0.00371	CcSEcCtD
Dalfampridine—Dyspepsia—Irinotecan—pancreatic cancer	0.00215	0.0037	CcSEcCtD
Dalfampridine—Immune system disorder—Docetaxel—pancreatic cancer	0.00215	0.0037	CcSEcCtD
Dalfampridine—Headache—Erlotinib—pancreatic cancer	0.00215	0.0037	CcSEcCtD
Dalfampridine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00214	0.00369	CcSEcCtD
Dalfampridine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00214	0.00368	CcSEcCtD
Dalfampridine—Asthenia—Sunitinib—pancreatic cancer	0.00213	0.00366	CcSEcCtD
Dalfampridine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00212	0.00365	CcSEcCtD
Dalfampridine—Insomnia—Fluorouracil—pancreatic cancer	0.00212	0.00364	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00211	0.00363	CcSEcCtD
Dalfampridine—Paraesthesia—Fluorouracil—pancreatic cancer	0.0021	0.00362	CcSEcCtD
Dalfampridine—Constipation—Irinotecan—pancreatic cancer	0.00209	0.0036	CcSEcCtD
Dalfampridine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00209	0.00359	CcSEcCtD
Dalfampridine—Mental disorder—Docetaxel—pancreatic cancer	0.00208	0.00359	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00207	0.00357	CcSEcCtD
Dalfampridine—Dyspepsia—Fluorouracil—pancreatic cancer	0.00206	0.00355	CcSEcCtD
Dalfampridine—Nausea—Tamoxifen—pancreatic cancer	0.00206	0.00354	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00205	0.00354	CcSEcCtD
Dalfampridine—Constipation—Gemcitabine—pancreatic cancer	0.00203	0.0035	CcSEcCtD
Dalfampridine—Nausea—Erlotinib—pancreatic cancer	0.00203	0.0035	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00202	0.00348	CcSEcCtD
Dalfampridine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00201	0.00347	CcSEcCtD
Dalfampridine—Back pain—Docetaxel—pancreatic cancer	0.002	0.00345	CcSEcCtD
Dalfampridine—Dizziness—Sunitinib—pancreatic cancer	0.00196	0.00338	CcSEcCtD
Dalfampridine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00196	0.00338	CcSEcCtD
Dalfampridine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00193	0.00332	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00192	0.0033	CcSEcCtD
Dalfampridine—Vomiting—Sunitinib—pancreatic cancer	0.00189	0.00325	CcSEcCtD
Dalfampridine—Rash—Sunitinib—pancreatic cancer	0.00187	0.00322	CcSEcCtD
Dalfampridine—Dermatitis—Sunitinib—pancreatic cancer	0.00187	0.00322	CcSEcCtD
Dalfampridine—Urticaria—Fluorouracil—pancreatic cancer	0.00186	0.0032	CcSEcCtD
Dalfampridine—Headache—Sunitinib—pancreatic cancer	0.00186	0.0032	CcSEcCtD
Dalfampridine—Hypersensitivity—Irinotecan—pancreatic cancer	0.0018	0.0031	CcSEcCtD
Dalfampridine—Convulsion—Docetaxel—pancreatic cancer	0.00179	0.00309	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—pancreatic cancer	0.00179	0.00308	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—pancreatic cancer	0.00179	0.00308	CcSEcCtD
Dalfampridine—Chest pain—Docetaxel—pancreatic cancer	0.00176	0.00303	CcSEcCtD
Dalfampridine—Nausea—Sunitinib—pancreatic cancer	0.00176	0.00303	CcSEcCtD
Dalfampridine—Asthenia—Irinotecan—pancreatic cancer	0.00175	0.00302	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00175	0.00301	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—pancreatic cancer	0.00174	0.00299	CcSEcCtD
Dalfampridine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00172	0.00297	CcSEcCtD
Dalfampridine—Asthenia—Gemcitabine—pancreatic cancer	0.00171	0.00294	CcSEcCtD
Dalfampridine—Confusional state—Docetaxel—pancreatic cancer	0.0017	0.00293	CcSEcCtD
Dalfampridine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00169	0.00291	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—AHR—pancreatic cancer	0.00169	0.00619	CbGpPWpGaD
Dalfampridine—Infection—Docetaxel—pancreatic cancer	0.00168	0.00289	CcSEcCtD
Dalfampridine—Nervous system disorder—Docetaxel—pancreatic cancer	0.00166	0.00285	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—pancreatic cancer	0.00165	0.00285	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—pancreatic cancer	0.00165	0.00285	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—TSC2—pancreatic cancer	0.00165	0.00606	CbGpPWpGaD
Dalfampridine—Skin disorder—Docetaxel—pancreatic cancer	0.00164	0.00283	CcSEcCtD
Dalfampridine—Dizziness—Irinotecan—pancreatic cancer	0.00161	0.00278	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00161	0.00277	CcSEcCtD
Dalfampridine—Hypotension—Docetaxel—pancreatic cancer	0.00158	0.00272	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00157	0.00271	CcSEcCtD
Dalfampridine—Vomiting—Irinotecan—pancreatic cancer	0.00155	0.00268	CcSEcCtD
Dalfampridine—Dizziness—Fluorouracil—pancreatic cancer	0.00155	0.00266	CcSEcCtD
Dalfampridine—Rash—Irinotecan—pancreatic cancer	0.00154	0.00265	CcSEcCtD
Dalfampridine—Dermatitis—Irinotecan—pancreatic cancer	0.00154	0.00265	CcSEcCtD
Dalfampridine—Headache—Irinotecan—pancreatic cancer	0.00153	0.00264	CcSEcCtD
Dalfampridine—Insomnia—Docetaxel—pancreatic cancer	0.00153	0.00263	CcSEcCtD
Dalfampridine—Paraesthesia—Docetaxel—pancreatic cancer	0.00152	0.00261	CcSEcCtD
Dalfampridine—Vomiting—Gemcitabine—pancreatic cancer	0.00151	0.00261	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—NFKBIA—pancreatic cancer	0.00151	0.00553	CbGpPWpGaD
Dalfampridine—Dyspnoea—Docetaxel—pancreatic cancer	0.00151	0.00259	CcSEcCtD
Dalfampridine—Rash—Gemcitabine—pancreatic cancer	0.0015	0.00258	CcSEcCtD
Dalfampridine—Dermatitis—Gemcitabine—pancreatic cancer	0.0015	0.00258	CcSEcCtD
Dalfampridine—Headache—Gemcitabine—pancreatic cancer	0.00149	0.00257	CcSEcCtD
Dalfampridine—Vomiting—Fluorouracil—pancreatic cancer	0.00149	0.00256	CcSEcCtD
Dalfampridine—Dyspepsia—Docetaxel—pancreatic cancer	0.00149	0.00256	CcSEcCtD
Dalfampridine—Rash—Fluorouracil—pancreatic cancer	0.00147	0.00254	CcSEcCtD
Dalfampridine—Dermatitis—Fluorouracil—pancreatic cancer	0.00147	0.00254	CcSEcCtD
Dalfampridine—Headache—Fluorouracil—pancreatic cancer	0.00147	0.00252	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00146	0.00251	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00146	0.00251	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—EZH2—pancreatic cancer	0.00146	0.00535	CbGpPWpGaD
Dalfampridine—Angiopathy—Epirubicin—pancreatic cancer	0.00145	0.00251	CcSEcCtD
Dalfampridine—Nausea—Irinotecan—pancreatic cancer	0.00145	0.0025	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—pancreatic cancer	0.00145	0.00249	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00144	0.00249	CcSEcCtD
Dalfampridine—Constipation—Docetaxel—pancreatic cancer	0.00144	0.00249	CcSEcCtD
Dalfampridine—KCNF1—islet of Langerhans—pancreatic cancer	0.00143	0.135	CbGeAlD
Dalfampridine—Nausea—Gemcitabine—pancreatic cancer	0.00141	0.00243	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—pancreatic cancer	0.0014	0.00242	CcSEcCtD
Dalfampridine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00139	0.0024	CcSEcCtD
Dalfampridine—Nausea—Fluorouracil—pancreatic cancer	0.00139	0.00239	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—pancreatic cancer	0.00135	0.00233	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—pancreatic cancer	0.00135	0.00232	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—pancreatic cancer	0.00134	0.00231	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00134	0.0023	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—pancreatic cancer	0.0013	0.00224	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.00128	0.00471	CbGpPWpGaD
Dalfampridine—KCNA5—islet of Langerhans—pancreatic cancer	0.00128	0.121	CbGeAlD
Dalfampridine—KCNH7—Circadian rythm related genes—EZH2—pancreatic cancer	0.00127	0.00467	CbGpPWpGaD
Dalfampridine—Back pain—Doxorubicin—pancreatic cancer	0.00125	0.00215	CcSEcCtD
Dalfampridine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00124	0.00214	CcSEcCtD
Dalfampridine—Asthenia—Docetaxel—pancreatic cancer	0.00121	0.00209	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00121	0.00444	CbGpPWpGaD
Dalfampridine—Convulsion—Epirubicin—pancreatic cancer	0.00121	0.00208	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—pancreatic cancer	0.00119	0.00205	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—pancreatic cancer	0.00118	0.00204	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00118	0.00203	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00116	0.00428	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRP1—pancreatic cancer	0.00115	0.00423	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRP1—pancreatic cancer	0.00115	0.00423	CbGpPWpGaD
Dalfampridine—Confusional state—Epirubicin—pancreatic cancer	0.00115	0.00198	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00114	0.00196	CcSEcCtD
Dalfampridine—Infection—Epirubicin—pancreatic cancer	0.00113	0.00195	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—pancreatic cancer	0.00112	0.00193	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—pancreatic cancer	0.00112	0.00192	CcSEcCtD
Dalfampridine—Dizziness—Docetaxel—pancreatic cancer	0.00112	0.00192	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—ACVR1B—pancreatic cancer	0.00111	0.00409	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NR5A2—pancreatic cancer	0.00111	0.00409	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NR5A2—pancreatic cancer	0.00111	0.00409	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ACVR1B—pancreatic cancer	0.00111	0.00409	CbGpPWpGaD
Dalfampridine—Skin disorder—Epirubicin—pancreatic cancer	0.00111	0.00191	CcSEcCtD
Dalfampridine—KCNA3—digestive system—pancreatic cancer	0.0011	0.104	CbGeAlD
Dalfampridine—Chest pain—Doxorubicin—pancreatic cancer	0.0011	0.00189	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—pancreatic cancer	0.0011	0.00189	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00109	0.00188	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.00108	0.00395	CbGpPWpGaD
Dalfampridine—Vomiting—Docetaxel—pancreatic cancer	0.00107	0.00185	CcSEcCtD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—pancreatic cancer	0.00107	0.00391	CbGpPWpGaD
Dalfampridine—Rash—Docetaxel—pancreatic cancer	0.00106	0.00183	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—pancreatic cancer	0.00106	0.00183	CcSEcCtD
Dalfampridine—Dermatitis—Docetaxel—pancreatic cancer	0.00106	0.00183	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—pancreatic cancer	0.00106	0.00183	CcSEcCtD
Dalfampridine—Headache—Docetaxel—pancreatic cancer	0.00106	0.00182	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—TYMS—pancreatic cancer	0.00105	0.00387	CbGpPWpGaD
Dalfampridine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00105	0.00182	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—pancreatic cancer	0.00105	0.0018	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00103	0.00178	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—pancreatic cancer	0.00103	0.00177	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—CASP3—pancreatic cancer	0.00103	0.00377	CbGpPWpGaD
Dalfampridine—Skin disorder—Doxorubicin—pancreatic cancer	0.00102	0.00176	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—pancreatic cancer	0.00102	0.00176	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—pancreatic cancer	0.00102	0.00175	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—PDX1—pancreatic cancer	0.00101	0.0037	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PDX1—pancreatic cancer	0.00101	0.0037	CbGpPWpGaD
Dalfampridine—Nausea—Docetaxel—pancreatic cancer	0.001	0.00173	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—pancreatic cancer	0.001	0.00173	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.000991	0.00364	CbGpPWpGaD
Dalfampridine—Hypotension—Doxorubicin—pancreatic cancer	0.000985	0.0017	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000983	0.00169	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—pancreatic cancer	0.000974	0.00168	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—pancreatic cancer	0.000953	0.00164	CcSEcCtD
Dalfampridine—KCND3—islet of Langerhans—pancreatic cancer	0.000952	0.0897	CbGeAlD
Dalfampridine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000946	0.00163	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000939	0.00162	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000938	0.00162	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000927	0.0016	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—TYMS—pancreatic cancer	0.000922	0.00338	CbGpPWpGaD
Dalfampridine—KCNQ1—islet of Langerhans—pancreatic cancer	0.000922	0.0868	CbGeAlD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000917	0.00337	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00091	0.00157	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—pancreatic cancer	0.000905	0.00156	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—pancreatic cancer	0.000901	0.00155	CcSEcCtD
Dalfampridine—KCNA5—pancreas—pancreatic cancer	0.000899	0.0847	CbGeAlD
Dalfampridine—KCNA3—BDNF signaling pathway—SRC—pancreatic cancer	0.000895	0.00329	CbGpPWpGaD
Dalfampridine—KCNS3—pancreas—pancreatic cancer	0.000881	0.0829	CbGeAlD
Dalfampridine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000868	0.0015	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—STAT3—pancreatic cancer	0.000863	0.00317	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000839	0.00145	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—pancreatic cancer	0.000837	0.00144	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—NRP1—pancreatic cancer	0.000822	0.00302	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRP1—pancreatic cancer	0.000822	0.00302	CbGpPWpGaD
Dalfampridine—Asthenia—Epirubicin—pancreatic cancer	0.000817	0.00141	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000776	0.00134	CcSEcCtD
Dalfampridine—KCNA5—digestive system—pancreatic cancer	0.000768	0.0723	CbGeAlD
Dalfampridine—Asthenia—Doxorubicin—pancreatic cancer	0.000756	0.0013	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—pancreatic cancer	0.000753	0.0013	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—PPARG—pancreatic cancer	0.000747	0.00274	CbGpPWpGaD
Dalfampridine—Vomiting—Epirubicin—pancreatic cancer	0.000724	0.00125	CcSEcCtD
Dalfampridine—Rash—Epirubicin—pancreatic cancer	0.000718	0.00124	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—pancreatic cancer	0.000717	0.00124	CcSEcCtD
Dalfampridine—Headache—Epirubicin—pancreatic cancer	0.000713	0.00123	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000698	0.00256	CbGpPWpGaD
Dalfampridine—Dizziness—Doxorubicin—pancreatic cancer	0.000697	0.0012	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—PRSS1—pancreatic cancer	0.000688	0.00253	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PRSS1—pancreatic cancer	0.000688	0.00253	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PRSS1—pancreatic cancer	0.000688	0.00253	CbGpPWpGaD
Dalfampridine—Nausea—Epirubicin—pancreatic cancer	0.000676	0.00117	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—pancreatic cancer	0.00067	0.00115	CcSEcCtD
Dalfampridine—KCND3—pancreas—pancreatic cancer	0.000669	0.063	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000668	0.00245	CbGpPWpGaD
Dalfampridine—Rash—Doxorubicin—pancreatic cancer	0.000664	0.00114	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—pancreatic cancer	0.000664	0.00114	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000663	0.00243	CbGpPWpGaD
Dalfampridine—Headache—Doxorubicin—pancreatic cancer	0.00066	0.00114	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—PPARG—pancreatic cancer	0.000653	0.0024	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PRSS1—pancreatic cancer	0.000652	0.00239	CbGpPWpGaD
Dalfampridine—KCNQ1—pancreas—pancreatic cancer	0.000648	0.061	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000644	0.00236	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—SRC—pancreatic cancer	0.000638	0.00234	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—SRC—pancreatic cancer	0.000638	0.00234	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SLC2A2—pancreatic cancer	0.000636	0.00233	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SLC2A2—pancreatic cancer	0.000636	0.00233	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—HRAS—pancreatic cancer	0.00063	0.00231	CbGpPWpGaD
Dalfampridine—Nausea—Doxorubicin—pancreatic cancer	0.000626	0.00108	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—IAPP—pancreatic cancer	0.000603	0.00221	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IAPP—pancreatic cancer	0.000603	0.00221	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ARG2—pancreatic cancer	0.000597	0.00219	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ARG2—pancreatic cancer	0.000597	0.00219	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ARG2—pancreatic cancer	0.000597	0.00219	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000567	0.00208	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ARG2—pancreatic cancer	0.000565	0.00208	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—pancreatic cancer	0.000559	0.00205	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—pancreatic cancer	0.000559	0.00205	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—AKT1—pancreatic cancer	0.000556	0.00204	CbGpPWpGaD
Dalfampridine—KCNQ1—digestive system—pancreatic cancer	0.000553	0.0521	CbGeAlD
Dalfampridine—KCNG2—Metabolism—TYMP—pancreatic cancer	0.000521	0.00191	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMP—pancreatic cancer	0.000521	0.00191	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMP—pancreatic cancer	0.000521	0.00191	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000519	0.0019	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PTEN—pancreatic cancer	0.000512	0.00188	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMP—pancreatic cancer	0.000494	0.00181	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000486	0.00178	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000475	0.00174	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PTEN—pancreatic cancer	0.000448	0.00164	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KDR—pancreatic cancer	0.000426	0.00156	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KDR—pancreatic cancer	0.000426	0.00156	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GLP1R—pancreatic cancer	0.00042	0.00154	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GLP1R—pancreatic cancer	0.00042	0.00154	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GLP1R—pancreatic cancer	0.00042	0.00154	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—pancreatic cancer	0.000417	0.00153	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MET—pancreatic cancer	0.000417	0.00153	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—HRAS—pancreatic cancer	0.000416	0.00153	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—DPYD—pancreatic cancer	0.000413	0.00152	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—DPYD—pancreatic cancer	0.000413	0.00152	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—DPYD—pancreatic cancer	0.000413	0.00152	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GLP1R—pancreatic cancer	0.000398	0.00146	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000398	0.00146	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A2—pancreatic cancer	0.000392	0.00144	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A2—pancreatic cancer	0.000392	0.00144	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A2—pancreatic cancer	0.000392	0.00144	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—DPYD—pancreatic cancer	0.000392	0.00144	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SMAD4—pancreatic cancer	0.000389	0.00143	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SMAD4—pancreatic cancer	0.000389	0.00143	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HES1—pancreatic cancer	0.000379	0.00139	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HES1—pancreatic cancer	0.000379	0.00139	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A2—pancreatic cancer	0.000372	0.00137	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—pancreatic cancer	0.000371	0.00136	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—pancreatic cancer	0.000354	0.0013	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—pancreatic cancer	0.000354	0.0013	CbGpPWpGaD
Dalfampridine—KCNH2—islet of Langerhans—pancreatic cancer	0.000351	0.0331	CbGeAlD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—pancreatic cancer	0.00035	0.00128	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—pancreatic cancer	0.000348	0.00128	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—pancreatic cancer	0.000348	0.00128	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—pancreatic cancer	0.000306	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—pancreatic cancer	0.000304	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—pancreatic cancer	0.000304	0.00112	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD44—pancreatic cancer	0.000304	0.00112	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD44—pancreatic cancer	0.000304	0.00112	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD44—pancreatic cancer	0.000304	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—pancreatic cancer	0.000298	0.00109	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—pancreatic cancer	0.000298	0.00109	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—pancreatic cancer	0.000297	0.00109	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—pancreatic cancer	0.000297	0.00109	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—pancreatic cancer	0.000297	0.00109	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GCG—pancreatic cancer	0.000291	0.00107	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GCG—pancreatic cancer	0.000291	0.00107	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GCG—pancreatic cancer	0.000291	0.00107	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—pancreatic cancer	0.000289	0.00106	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD44—pancreatic cancer	0.000288	0.00106	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NOTCH1—pancreatic cancer	0.000286	0.00105	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NOTCH1—pancreatic cancer	0.000286	0.00105	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—pancreatic cancer	0.000281	0.00103	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GCG—pancreatic cancer	0.000276	0.00101	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—STK11—pancreatic cancer	0.000274	0.00101	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—STK11—pancreatic cancer	0.000274	0.00101	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—STK11—pancreatic cancer	0.000274	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—pancreatic cancer	0.00027	0.000993	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—pancreatic cancer	0.00027	0.000993	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—pancreatic cancer	0.000261	0.00096	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—pancreatic cancer	0.000261	0.00096	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—STK11—pancreatic cancer	0.00026	0.000953	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000258	0.000948	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—pancreatic cancer	0.000257	0.000945	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—pancreatic cancer	0.000257	0.000945	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—pancreatic cancer	0.000252	0.000926	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—pancreatic cancer	0.000248	0.000911	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—pancreatic cancer	0.000248	0.000911	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000247	0.000908	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—pancreatic cancer	0.000241	0.000885	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—pancreatic cancer	0.000241	0.000885	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000238	0.000875	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMS—pancreatic cancer	0.000236	0.000865	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMS—pancreatic cancer	0.000236	0.000865	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TYMS—pancreatic cancer	0.000236	0.000865	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—pancreatic cancer	0.000235	0.000862	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—pancreatic cancer	0.000235	0.000862	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—pancreatic cancer	0.000232	0.000851	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—pancreatic cancer	0.000232	0.000851	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—pancreatic cancer	0.000228	0.000838	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—pancreatic cancer	0.000225	0.000826	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMS—pancreatic cancer	0.000223	0.00082	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—pancreatic cancer	0.000211	0.000776	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—pancreatic cancer	0.000211	0.000776	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.00021	0.00077	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—pancreatic cancer	0.0002	0.000733	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—pancreatic cancer	0.0002	0.000733	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—pancreatic cancer	0.000192	0.000703	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—pancreatic cancer	0.000192	0.000703	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—pancreatic cancer	0.000192	0.000703	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—pancreatic cancer	0.000191	0.000702	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—pancreatic cancer	0.000191	0.000702	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—pancreatic cancer	0.00019	0.000699	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—pancreatic cancer	0.00019	0.000699	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—pancreatic cancer	0.000187	0.000685	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—pancreatic cancer	0.000187	0.000685	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—pancreatic cancer	0.000182	0.000667	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.00018	0.00066	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—pancreatic cancer	0.000173	0.000635	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—pancreatic cancer	0.000173	0.000635	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—pancreatic cancer	0.000173	0.000635	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—pancreatic cancer	0.000172	0.000632	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—pancreatic cancer	0.000172	0.000632	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—pancreatic cancer	0.00017	0.000623	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—pancreatic cancer	0.00017	0.000623	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—pancreatic cancer	0.000168	0.000615	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—pancreatic cancer	0.000168	0.000615	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—pancreatic cancer	0.000167	0.000613	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—pancreatic cancer	0.000167	0.000613	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—pancreatic cancer	0.000167	0.000613	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—pancreatic cancer	0.000166	0.000609	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—pancreatic cancer	0.000166	0.000609	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—pancreatic cancer	0.000166	0.000608	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—pancreatic cancer	0.000166	0.000608	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—pancreatic cancer	0.000164	0.000602	CbGpPWpGaD
Dalfampridine—CYP2E1—digestive system—pancreatic cancer	0.000162	0.0153	CbGeAlD
Dalfampridine—KCNB1—Metabolism—PPARG—pancreatic cancer	0.000158	0.000581	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—pancreatic cancer	0.000154	0.000565	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—pancreatic cancer	0.000154	0.000565	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—pancreatic cancer	0.000152	0.000558	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—pancreatic cancer	0.000152	0.000558	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—pancreatic cancer	0.000152	0.000558	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—pancreatic cancer	0.000151	0.000554	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—pancreatic cancer	0.000151	0.000554	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—pancreatic cancer	0.000144	0.000529	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—pancreatic cancer	0.000144	0.000527	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—pancreatic cancer	0.000144	0.000527	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—pancreatic cancer	0.000142	0.000523	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—pancreatic cancer	0.000142	0.000523	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—pancreatic cancer	0.000133	0.000486	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—pancreatic cancer	0.000133	0.000486	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—pancreatic cancer	0.000133	0.000486	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—pancreatic cancer	0.000131	0.000482	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—pancreatic cancer	0.000131	0.000482	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—pancreatic cancer	0.000131	0.000482	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—pancreatic cancer	0.000126	0.000461	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—pancreatic cancer	0.000124	0.000457	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—pancreatic cancer	0.000121	0.000444	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—pancreatic cancer	0.000121	0.000444	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—pancreatic cancer	0.000114	0.00042	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—pancreatic cancer	0.000114	0.00042	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—pancreatic cancer	0.000114	0.00042	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—pancreatic cancer	0.000109	0.000398	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—pancreatic cancer	0.000107	0.000392	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—pancreatic cancer	0.000107	0.000392	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PRSS1—pancreatic cancer	0.0001	0.000367	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—pancreatic cancer	9.52e-05	0.00035	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ARG2—pancreatic cancer	8.67e-05	0.000318	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—pancreatic cancer	8.08e-05	0.000297	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—pancreatic cancer	8.08e-05	0.000297	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—pancreatic cancer	8.08e-05	0.000297	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—pancreatic cancer	7.66e-05	0.000281	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMP—pancreatic cancer	7.58e-05	0.000278	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—pancreatic cancer	6.6e-05	0.000242	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—pancreatic cancer	6.6e-05	0.000242	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—pancreatic cancer	6.6e-05	0.000242	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—pancreatic cancer	6.26e-05	0.00023	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLP1R—pancreatic cancer	6.11e-05	0.000224	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DPYD—pancreatic cancer	6.01e-05	0.000221	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	5.7e-05	0.000209	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD44—pancreatic cancer	4.41e-05	0.000162	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCG—pancreatic cancer	4.23e-05	0.000155	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STK11—pancreatic cancer	3.98e-05	0.000146	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMS—pancreatic cancer	3.42e-05	0.000126	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—pancreatic cancer	2.78e-05	0.000102	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	2.51e-05	9.22e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—pancreatic cancer	2.42e-05	8.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	2.21e-05	8.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	1.93e-05	7.07e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	1.91e-05	7e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—pancreatic cancer	1.66e-05	6.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.17e-05	4.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—pancreatic cancer	9.59e-06	3.52e-05	CbGpPWpGaD
